Erasca, Inc.
USD19.38
+0.56 (+2.98%)
CEO
Jonathan E. Lim
IPO Date
2021-07-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.01
Prev. Close
$18.82
Day Low
$18.70
Day High
$19.59
52W Low
$1.33
52W High
$24.28
Market Cap
$6.03B
Volume
2.37M
| 29,888 |
| $16.01 |
| 29 Jun 2026 | Multani Pratik S | director | A-Award | Acquired | 29,888 | $16.01 |
| 29 Jun 2026 | Casdin Alexander W. | director | A-Award | Acquired | 29,888 | $16.01 |
| 29 Jun 2026 | Hambleton Julie | director | A-Award | Acquired | 29,888 | $16.01 |
| 29 Jun 2026 | Bristol James Arthur | director | A-Award | Acquired | 29,888 | $16.01 |
| 3 Apr 2026 | Garner Ebun | Chief Legal Officer | M-Exempt | Acquired | 80,000 | $1.70 |
| 3 Apr 2026 | Garner Ebun | Chief Legal Officer | S-Sale | Disposed | 80,000 | $16.40 |
| 3 Apr 2026 | Garner Ebun | Chief Legal Officer | M-Exempt | Disposed | 80,000 | $1.70 |
| 6 Mar 2026 | Morris Shannon | Chief Medical Officer | M-Exempt | Acquired | 20,000 | $1.70 |